These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1104 related articles for article (PubMed ID: 3969521)

  • 1. Cytostatic drug effects on human clonogenic tumor cells and human bone marrow progenitor cells (CFU-C) in vitro.
    Neumann HA; Fiebig HH; Engelhardt R; Löhr GW
    Res Exp Med (Berl); 1985; 185(1):51-6. PubMed ID: 3969521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human bone marrow progenitors (CFU-C) and human clonogenic tumor cells implanted into mice.
    Neumann HA; Fiebig HH; Löhr GW; Engelhardt R
    J Natl Cancer Inst; 1985 Dec; 75(6):1059-66. PubMed ID: 2999496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human clonogenic tumor cells.
    Neumann HA; Fiebig HH; Löhr GW; Engelhardt R
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):515-23. PubMed ID: 2988968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development.
    Fiebig HH; Schmid JR; Bieser W; Henss H; Lohr GW
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):937-48. PubMed ID: 3665999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of human clonogenic tumor cells and bone marrow progenitor cells with bleomycin and peplomycin under 40.5 degrees C hyperthermia in vitro.
    Neumann HA; Herrmann DB; Fiebig HH; Engelhardt R
    Eur J Cancer Clin Oncol; 1989 Jan; 25(1):99-104. PubMed ID: 2465897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
    Taetle R; Koessler AK; Howel SB
    Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
    Ajani JA; Blaauw AA; Spitzer G; Baker FL; Tomasovic B; Umbach G; Thielvoldt D; Zander AR; Dicke KA
    Exp Hematol; 1985; 13 Suppl 16():95-100. PubMed ID: 2580731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the activity of doxorubicin analogues using colony-forming assays and human xenografts.
    Taetle R; Howell SB; Giuliani FC; Koziol J; Koessler A
    Cancer; 1982 Oct; 50(8):1455-61. PubMed ID: 6956427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clonogenic cultures of human tumors. Potentials and difficulties].
    Rozencweig M; Sanders C; Rombaut W; Kenis Y; Klastersky J; Decoster G
    Rev Med Liege; 1984 Feb; 39(3):134-7. PubMed ID: 6718867
    [No Abstract]   [Full Text] [Related]  

  • 11. TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.
    Plasilova M; Zivny J; Jelinek J; Neuwirtova R; Cermak J; Necas E; Andera L; Stopka T
    Leukemia; 2002 Jan; 16(1):67-73. PubMed ID: 11840265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
    Young JW; Szabolcs P; Moore MA
    J Exp Med; 1995 Oct; 182(4):1111-9. PubMed ID: 7561684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays.
    Umbach GE; Hug V; Spitzer G; Tomasovic B; Thames H; Ajani JA; Drewinko B
    J Cancer Res Clin Oncol; 1985; 109(2):130-4. PubMed ID: 3980561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
    Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
    Stahel RA; Mabry M; Sabbath K; Speak JA; Bernal SD
    Int J Cancer; 1985 May; 35(5):587-92. PubMed ID: 2987136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of nude mouse xenografts as preclinical drug screens. Further studies on in vitro growth of xenograft tumor colony-forming cells.
    Taetle R; Honeysett JM; Rosen F; Shoemaker R
    Cancer; 1986 Nov; 58(9):1969-78. PubMed ID: 3756816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J; Fehér I
    Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.